Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Alvin Zipursky, Toby Rose, Martin Skidmore, Paul Thorner & John Doyle. (1996) Hydrops Fetalis and Neonatal Leukemia in Down Syndrome. Pediatric Hematology and Oncology 13:1, pages 81-87.
Read now
Read now
Articles from other publishers (22)
Kenichiro Kobayashi, Atsushi Iwai, Kuniaki Tanaka, Shumpei Mizuta, Saya Yoshida, Toshiro Maihara, Yoshinobu Nishida, Takahito Wada, Ikuya Usami & Toshio Heike. (2022) Low-Level Germline 48,XYY,+21 Mosaicism Associated with Transient Abnormal Myelopoiesis in a Phenotypically Normal Neonate. Cytogenetic and Genome Research 162:11-12, pages 625-631.
Crossref
Crossref
Koya Kawase, Eiichi Azuma, Hironori Ohshita, Tatsushi Tanaka, Yu Hanada, Tomoaki Sasaki, Mari Sugimoto, Takao Togawa, Masanori Kouwaki, Tsuyoshi Ito, Masahiro Hirayama & Norihisa Koyama. (2012) Risk Factors for Early Death in Transient Myeloproliferative Disorder Without Phenotypic Features of Down Syndrome. Journal of Pediatric Hematology/Oncology 34:6, pages 475-479.
Crossref
Crossref
David R. Czuchlewski, Haleh Farzanmehr, Sheldon Robinett, Skip Haines & Kaaren K. Reichard. (2011) t(9;22)(q34;q11.2) is a recurrent constitutional non-Robertsonian translocation and a rare cytogenetic mimic of chronic myeloid leukemia. Cancer Genetics 204:10, pages 572-576.
Crossref
Crossref
Stanley Chaleff. 2011. Diagnostic Pediatric Hematopathology. Diagnostic Pediatric Hematopathology
345
356
.
John Kim Choi. 2011. Diagnostic Pediatric Hematopathology. Diagnostic Pediatric Hematopathology
310
322
.
Kazuko Kudo, Asahito Hama, Seiji Kojima, Ruriko Ishii, Akira Morimoto, Fumio Bessho, Shosuke Sunami, Naoyuki Kobayashi, Akitoshi Kinoshita, Yuri Okimoto, Akio Tawa & Ichiro Tsukimoto. (2010) Mosaic Down syndrome-associated acute myeloid leukemia does not require high-dose cytarabine treatment for induction and consolidation therapy. International Journal of Hematology 91:4, pages 630-635.
Crossref
Crossref
V. Li-Thiao-Te, E. Bourges-Petit, J.C. Capiod, B. Horle, J. Micheli, G. Morin, Y. Maingourd & B. Pautard. (2008) Un cas de leucémie congénitale transitoire. Archives de Pédiatrie 15:1, pages 33-36.
Crossref
Crossref
Brandie Heald, Joanne M Hilden, Kevin Zbuk, Alice Norton, Paresh Vyas, Karl S Theil & Charis Eng. (2007) Severe TMD/AMKL with GATA1 mutation in a stillborn fetus with Down syndrome. Nature Clinical Practice Oncology 4:7, pages 433-438.
Crossref
Crossref
Robert J. Arceci. 2007. Acute Myelogenous Leukemia. Acute Myelogenous Leukemia
345
372
.
Gita V. MasseyAlvin ZipurskyMyron N. ChangJohn J. DoyleSuhail NasimJeffrey W. TaubYaddanapudi RavindranathGary DahlHoward J. Weinstein. (2006) A prospective study of the natural history of transient leukemia (TL) in neonates with Down syndrome (DS): Children's Oncology Group (COG) study POG-9481. Blood 107:12, pages 4606-4613.
Crossref
Crossref
Fred G. Behm. 2010. Childhood Leukemias. Childhood Leukemias
150
209
.
Claudio Sandoval, Sharon R. Pine, Qianxu Guo, Sudha Sastry, Julian Stewart, David Kronn & Somasundaram Jayabose. (2005) Tetrasomy 21 transient leukemia with aGATA1 mutation in a phenotypically normal trisomy 21 mosaic infant: Case report and review of the literature. Pediatric Blood & Cancer 44:1, pages 85-91.
Crossref
Crossref
Gita V. Massey. (2005) Transient leukemia in newborns with Down syndrome. Pediatric Blood & Cancer 44:1, pages 29-32.
Crossref
Crossref
Hart Isaacs,Jr.Jr.. (2003) Fetal and Neonatal Leukemia. Journal of Pediatric Hematology/Oncology 25:5, pages 348-361.
Crossref
Crossref
Alvin Zipursky. (2003) Transient leukaemia – a benign form of leukaemia in newborn infants with trisomy 21. British Journal of Haematology 120:6, pages 930-938.
Crossref
Crossref
Fawaz Al-Kasim, John J. Doyle, Gita V. Massey, Howard J. Weinstein & Alvin Zipursky. (2002) Incidence and Treatment of Potentially Lethal Diseases in Transient Leukemia of Down Syndrome: Pediatric Oncology Group Study. Journal of Pediatric Hematology/Oncology 24:1, pages 9-13.
Crossref
Crossref
Hart IsaacsJr.Jr.. 2002. Tumors of the Fetus and Infant. Tumors of the Fetus and Infant
161
180
.
Fran�ois Girodon, Bernardine Favre, G�rard Couillaud, Paule-Marie Carli, Chantal Parmeland & Marc Maynadi�. (2000) Immunophenotype of a transient myeloproliferative disorder in a newborn with trisomy 21. Cytometry 42:2, pages 118-122.
Crossref
Crossref
Dorothée Duflos-Delaplace, Jean-Luc Laı̈, Brigitte Nelken, Franck Genevieve, Anne-Sophie Defachelles & Marc Zandecki. (1999) Transient Leukemoid Disorder in a Newborn with Down Syndrome Followed 19 Months Later by an Acute Myeloid Leukemia. Cancer Genetics and Cytogenetics 113:2, pages 166-171.
Crossref
Crossref
Zipursky Alvin, Elizabeth J. Brown, Christensen Hilary & Doyle John. (1999) Transient Myeloproliferative Disorder (Transient Leukemia) and Hematologic Manifestations of Down Syndrome. Clinics in Laboratory Medicine 19:1, pages 157-168.
Crossref
Crossref
Ivan P. G. Moskowitz, Paul S. Gaynon, Nasrollah T. Shahidi & Timothy P. Cripe. (1999) Low-Dose Cyclosporin A Therapy in Children With Refractory Immune Thrombocytopenic Purpura. Journal of Pediatric Hematology/Oncology 21:1, pages 77-79.
Crossref
Crossref
Alvin Zipursky, Elizabeth Brown, Hilary Christensen, Robert Sutherland & John Doyle. (1997) Leukemia and/or myeloproliferative syndrome in neonates with Down Syndrome. Seminars in Perinatology 21:1, pages 97-101.
Crossref
Crossref